相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Discovery of ML326: The first sub-micromolar, selective M5 PAM
Patrick R. Gentry et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu3 Selective and CNS Penetrant Negative Allosteric Modulator (NAM)
Cody J. Wenthur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discovery of the First M5-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (S)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)
Patrick R. Gentry et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Structural Modifications to Tetrahydropyridine-3-carboxylate Esters en Route to the Discovery of M5-Preferring Muscarinic Receptor Orthosteric Antagonists
Guangrong Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse, and Parkinson's Disease
Ditte Dencker et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery
Bruce J. Melancon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M5 PAM
Thomas M. Bridges et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Muscarinic Receptor Blockade in the Ventral Tegmental Area Attenuates Cocaine Enhancement of Laterodorsal Tegmentum Stimulation-Evoked Accumbens Dopamine Efflux in the Mouse
Deranda B. Lester et al.
SYNAPSE (2010)
Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-Trifluoromethoxy N-Benzyl Isatins
Thomas M. Bridges et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
A Novel Selective Muscarinic Acetylcholine Receptor Subtype 1 Antagonist Reduces Seizures without Impairing Hippocampus-Dependent Learning
Douglas J. Sheffler et al.
MOLECULAR PHARMACOLOGY (2009)
Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders
P. Jeffrey Conn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J. Langmead et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Juergen Wess et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice
M Thomsen et al.
JOURNAL OF NEUROSCIENCE (2005)
Role for M5 muscarinic acetylcholine receptors in cocaine addiction
A Fink-Jensen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia
AS Basile et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)